Pfizer Inc vs United States Oil ETF — how do they compare? Pfizer Inc trades at $27.9 (market cap $158.39B), while United States Oil ETF trades at $148.45. The key difference: Pfizer Inc pays a 6.19% dividend while United States Oil ETF pays none, and United States Oil ETF is trading nearer its 52-week high, Pfizer Inc nearer its low. Which is the better fit depends on your goals.
| PFE | USO | |
|---|---|---|
Market Cap | $158.39B | — |
Volume | 29,869,932 | — |
Sector | Health | — |
52-Week High | $29.02 | $152.96 |
52-Week Low | $23.60 | $66.17 |
Enterprise Value | $209.89B | — |
Dividend Yield | 6.19% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.
Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.
USO is trading at $146.03, up 2.87% amid strong bullish momentum driven by escalating Middle East tensions pushing oil prices higher. The technical picture shows overwhelming bullish signals with moving averages strongly supporting upward momentum, though oscillators indicate potential overbought conditions. Recent news highlights supply disruptions in the Strait of Hormuz driving Brent crude above $100 per barrel, creating favorable conditions for energy sector performance.
The outlook remains positive as geopolitical tensions continue to support oil prices, though elevated RSI levels suggest near-term consolidation risk. Key resistance at $147-$150 presents the next challenge, while support at $144-$142 provides downside protection. Energy sector strength appears sustainable given ongoing supply constraints and OPEC+ production discipline.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →